| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.CLIM.2005.07.008 |
| P698 | PubMed publication ID | 16112617 |
| P50 | author | Christian P. Fischer | Q44013919 |
| Bente Klarlund Pedersen | Q12303219 | ||
| P2093 | author name string | Annika Berntsen | |
| Peter Eskildsen | |||
| Lisbeth B Perstrup | |||
| P433 | issue | 2 | |
| P921 | main subject | preproinsulin | Q7240673 |
| interleukins | Q194908 | ||
| insulin resistance | Q1053470 | ||
| P304 | page(s) | 152-160 | |
| P577 | publication date | 2005-08-19 | |
| P1433 | published in | Clinical Immunology | Q15752921 |
| P1476 | title | Elevated plasma interleukin-18 is a marker of insulin-resistance in type 2 diabetic and non-diabetic humans | |
| P478 | volume | 117 |
| Q64071609 | A Positive Causal Influence of IL-18 Levels on the Risk of T2DM: A Mendelian Randomization Study |
| Q35941368 | A Study to Investigate the Efficacy and Safety of an Anti-Interleukin-18 Monoclonal Antibody in the Treatment of Type 2 Diabetes Mellitus |
| Q58209708 | Aberrant activation profile of cytokines and mitogen-activated protein kinases in type 2 diabetic patients with nephropathy |
| Q34779049 | Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease. |
| Q61762737 | Adipose Tissue Interleukin-18 mRNA and Plasma Interleukin-18: Effect of Obesity and Exercise* |
| Q46685753 | Adult subjects with Prader-Willi syndrome show more low-grade systemic inflammation than matched obese subjects |
| Q55221890 | Association of C-Reactive Protein and Other Markers of Inflammation with Risk of Complications in Diabetic Subjects. |
| Q36212090 | Association of adiponectin and metabolic syndrome in women |
| Q36287002 | Association of interleukin-18 gene polymorphism with body mass index in women |
| Q46956147 | Associations between insulin resistance and TNF-alpha in plasma, skeletal muscle and adipose tissue in humans with and without type 2 diabetes. |
| Q38187337 | Caspases and inflammasomes in metabolic inflammation |
| Q35829203 | Central obesity, type 2 diabetes and insulin: exploring a pathway full of thorns |
| Q37136196 | Circulating IL-18 and the risk of type 2 diabetes in women |
| Q34573680 | Circulating interleukin-18: A specific biomarker for atherosclerosis-prone patients with metabolic syndrome |
| Q36617125 | Cytokines in type 2 diabetes. |
| Q38294300 | Diet, behavior and immunity across the lifespan. |
| Q33385913 | Effect of diet-induced obesity on acute pancreatitis induced by administration of interleukin-12 plus interleukin-18 in mice |
| Q47280913 | Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumour necrosis factor-alpha receptors, C-reactive protein and adiponectin in morbidly obese patients |
| Q51391705 | Elevated serum levels of interleukin-18 in patients with overt diabetic nephropathy: effects of miglitol |
| Q51498308 | Elevation of plasma interleukin-18 concentration is associated with insulin levels in patients with systemic lupus erythematosus. |
| Q33731942 | Evaluation and integration of 49 genome-wide experiments and the prediction of previously unknown obesity-related genes |
| Q84644167 | Evaluation of cytokines and hormones in dogs before and after treatment of diabetic ketoacidosis and in uncomplicated diabetes mellitus |
| Q48534581 | Expression of mRNA and protein of IL-18 and its receptor in human follicular granulosa cells |
| Q45918376 | Felodipine downregulates serum interleukin-18 levels in rats with fructose-induced metabolic syndrome. |
| Q35172378 | Genetic variation within IL18 is associated with insulin levels, insulin resistance and postprandial measures |
| Q33740363 | Genome-wide association study identifies variants at the IL18-BCO2 locus associated with interleukin-18 levels |
| Q36005876 | IL-1 family members in the pathogenesis and treatment of metabolic disease: Focus on adipose tissue inflammation and insulin resistance |
| Q36761492 | Important genetic checkpoints for insulin resistance in salt-sensitive (S) Dahl rats |
| Q35044541 | Increased expression of IL-18 in the serum and islets of type 1 diabetics |
| Q83979184 | Increased serum interleukin-18 concentration is associated with hypoadiponectinemia in obesity, independently of insulin resistance |
| Q37174503 | Inflammation during obesity is not all bad: evidence from animal and human studies |
| Q35838041 | Inflammatory and oxidative stress responses to high-carbohydrate and high-fat meals in healthy humans |
| Q37420086 | Inhibition of hepatic interleukin-18 production by rosiglitazone in a rat model of nonalcoholic fatty liver disease. |
| Q47424568 | Interleukin-18 and testosterone levels in men with metabolic syndrome. |
| Q42817301 | Interleukin-18 enhances glucose uptake in 3T3-L1 adipocytes |
| Q81681379 | Interleukin-18 resistance in patients with obesity and type 2 diabetes mellitus |
| Q50021277 | Interleukin-18 serum level is elevated in type 2 diabetes and latent autoimmune diabetes. |
| Q38295214 | Interleukin-18 suppresses adiponectin expression in 3T3-L1 adipocytes via a novel signal transduction pathway involving ERK1/2-dependent NFATc4 phosphorylation |
| Q36725696 | Interleukin-18, together with interleukin-12, induces severe acute pancreatitis in obese but not in nonobese leptin-deficient mice |
| Q47285927 | Interleukin-18: Biological properties and role in disease pathogenesis |
| Q41820766 | Molecular and immunohistochemical effects of metformin in a rat model of type 2 diabetes mellitus |
| Q57587385 | Muscle ceramide content is similar after 3 weeks’ consumption of fat or carbohydrate diet in a crossover design in patients with type 2 diabetes |
| Q54260312 | Oxidative Stress and NLRP3-Inflammasome Activity as Significant Drivers of Diabetic Cardiovascular Complications: Therapeutic Implications. |
| Q52956251 | PKC-β activation inhibits IL-18-binding protein causing endothelial dysfunction and diabetic atherosclerosis. |
| Q37494520 | Pathogenesis and pathophysiology of accelerated atherosclerosis in the diabetic heart. |
| Q41675413 | Per os colchicine administration in cholesterol fed rabbits: Triglycerides lowering effects without affecting atherosclerosis progress |
| Q37298658 | Potential biomarkers of insulin resistance and atherosclerosis in type 2 diabetes mellitus patients with coronary artery disease. |
| Q37296393 | Potential role of interleukin-18 in patients with rheumatoid arthritis-associated carotid intima-media thickness but not insulin resistance |
| Q55365071 | Predictive Role of Interleukin-18 in Liver Steatosis in Obese Children. |
| Q43133879 | Relationship between insulin resistance, inflammation and liver cell apoptosis in patients with severe obesity. |
| Q34675053 | Selected dietary flavonoids are associated with markers of inflammation and endothelial dysfunction in U.S. women |
| Q46878866 | The anti-inflammatory effects of exercise training in patients with type 2 diabetes mellitus. |
| Q80184148 | The decrease in serum IL-18 levels after bariatric surgery in morbidly obese women is a time-dependent event |
| Q33304007 | The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitus |
| Q33804391 | The role of interleukin-18 in the metabolic syndrome |
| Q37462159 | The role of interleukins in insulin resistance and type 2 diabetes mellitus. |
| Q37650762 | Transcriptional and post-translational regulation of adiponectin |
Search more.